a public good project by the
Synthesis
Company
of California

© 2026

Ralph Mangusan | doi.page

0 works0 citations0 h-index

Ralph Mangusan

National Institutes of Health(US)National Cancer Institute(US)Center for Cancer Research(US)

Publications by Year

Research Areas

Viral-associated cancers and disorders, Lymphoma Diagnosis and Treatment, Histiocytic Disorders and Treatments, CNS Lymphoma Diagnosis and Treatment, Cardiac Valve Diseases and Treatments

Most-Cited Works

→ Rate Control versus Rhythm Control for Atrial Fibrillation after Cardiac Surgery(2016)387 cited
→ Outcomes Associated With Postoperative Delirium After Cardiac Surgery(2015)114 cited
→ Effect of Cerebral Embolic Protection Devices on CNS Infarction in Surgical Aortic Valve Replacement(2017)73 cited
→ Characteristics and outcomes of KSHV-associated multicentric Castleman disease with or without other KSHV diseases(2021)71 cited
→ Use of pembrolizumab with or without pomalidomide in HIV-associated non-Hodgkin’s lymphoma(2021)66 cited
→ Transcriptional landscape of Kaposi sarcoma tumors identifies unique immunologic signatures and key determinants of angiogenesis(2023)19 cited

→ Characteristics of patients admitted to the ICU with Kaposi sarcoma herpesvirus-associated diseases(2022)

18 cited

→ Treatment Outcomes and Prognostic Factors in 40 Patients with Primary Effusion Lymphoma(2021)7 cited

→ A phase I trial of pomalidomide in combination with liposomal doxorubicin in patients with Kaposi sarcoma with or without other KSHV-associated diseases.(2020)6 cited

→ Phase I Study of Lenalidomide Combined with Dose-Adjusted EPOCH and Rituximab (EPOCH-R2) in Primary Effusion Lymphoma in Participants with or without HIV (NCT02911142)(2020)5 cited